ArticleIJID regions2026
Epidemiology of Lyme disease, a growing tick-borne disease of concern, in Japan from May 2013 to March 2024: a descriptive study.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Lyme disease (LD) is a globally distributed zoonosis; however, limited epidemiological data are available from Japan. This study aimed to elucidate the characteristics of LD cases reported through the Japanese national surveillance system. Methods: We conducted a retrospective descriptive study based on data from the National Epidemiological Surveillance of Infectious Diseases for the fiscal years 2006-2023. Results: Overall, 265 LD cases were reported, ranging from five in 2008 to 28 in 2023 (median: 12.5), including 216 domestic, predominantly from Hokkaido, and 43 imported cases. The median annual notification rate for domestic cases was 0.94 per 10 million population (range: 0.39-2.14). The median age was 53 years, and 62% were male. No fatal cases were reported. Most infections occurred between May and September. Common clinical features of the cases included erythema migrans, fever, and neurological symptoms. The median duration from onset to diagnosis was 28.5 days (interquartile range: 16-45 days). Conclusions: The number of LD cases in Japan has increased, with cases predominantly occurring in middle-aged men from Hokkaido and other areas. Furthermore, patients having LD presented with non-specific symptoms, including neurological involvement, resulting in delayed diagnoses. These findings highlight the importance of increasing awareness of LD in Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.